Nye medlemmer

New company member: Biosynex Nordic

We are pleased to announced that Biosynex Nordics has become a member of the Chamber

We are pleased to announced that Biosynex Nordics has become a new company member of the Danish-French Chamber of Commerce. 

Biosynex Nordic A/S is a subsidiary of the French biotech company Biosynex SA, which since 2005 has focused on developing, producing and distributing high-quality products within in vitro diagnostics from their headquarter in Strasbourg. In recent years, Biosynex SA has grown into one of the leading companies in its industry, and is represented globally with a number of strong brands.

Biosynex Nordic is the exclusive importer from Biosynex SA in the Nordic market, which we offer to the Danish health care sector as well as a number of other products and services within in vitro diagnostics that meet our high quality standards.

We are happy to welcome them in the network and look forward to the future collaboration.

If you would like to learn more about Biosynex Nordic, please click here.

Artikler om samme emne

Job fair important information

You might have noticed that we posted information about a new edition of our annual job fair on our website a few weeks ago. We planned to organise…

Nyheder fra virksomheder

Relocare is happy to present 3 new employees

Relocare is happy to present 3 new employees: Carl-Fredrik Sundström is new CMO at Relocare Group, with responsibility for Denmark, Sweden, and…

Nyheder fra virksomheder

Rule of law: Community is our strongest card.

In many ways, 2025 proved to be a challenging year for the world, for the EU, for France and for Denmark. And already in this first month of 2026, we…

Tidligere arrangementer

Economic Outlook 2026

On Friday, 30 January 2026, the Danish-French Chamber of Commerce, in collaboration with the Benelux Business Club Scandinavia, organized its annual…

  1. 1
  2. 2
  3. 3
  4. 4
  5. ...
  6. 52

Arrangementer om samme emne

No event matches your search

FLERE NYHEDER

Share this page Share on FacebookShare on TwitterShare on Linkedin